What does CUSIP 640268108 represent in this 13F holders report?

CUSIP 640268108 is the security identifier for NKTR - Nektar Therapeutics - Common Stock used to aggregate holder disclosures.

How many institutions held NKTR - Nektar Therapeutics - Common Stock in Q1 2016?

172 institutional investors reported NKTR - Nektar Therapeutics - Common Stock for Q1 2016. Use the holders table for investor-level position and value details.

Nektar Therapeutics - Common Stock (NKTR)

CUSIP: 640268108

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class: Equity / Common Stock
Shares outstanding: 20,788,527
Total 13F shares: 139,138,306
Share change: -323,842
Total reported value: $1,913,174,245
Put/Call ratio: 92%
Price per share: $13.75
Number of holders: 172
Value change: -$6,784,614
Number of buys: 90
Number of sells: 81

Quarterly Holders Quick Answers

What is CUSIP 640268108?
CUSIP 640268108 identifies NKTR - Nektar Therapeutics - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2016
Previous quarter: Q4 2015

Recent filing periods for CUSIP 640268108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of NKTR - Nektar Therapeutics - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
OppenheimerFunds, Inc.	13F	Company	125%	26,003,375	$438,157,000	—	31 Dec 2015	13F
PRIMECAP MANAGEMENT CO/CA/	13F	Company	95%	19,784,286	$333,365,000	—	31 Dec 2015	13F
VANGUARD GROUP INC	13F	Company	50%	10,465,889	$176,351,000	—	31 Dec 2015	13F
BlackRock Fund Advisors	13F	Company	47%	9,857,716	$166,103,000	—	31 Dec 2015	13F
FIRST TRUST ADVISORS LP	13F	Company	46%	9,599,117	$161,745,000	—	31 Dec 2015	13F
Invesco Ltd.	13F	Company	21%	4,376,307	$73,741,000	—	31 Dec 2015	13F
FEDERATED HERMES, INC.	13F	Company	19%	3,878,921	$65,360,000	—	31 Dec 2015	13F
Camber Capital Management LP	13F	Company	17%	3,500,000	$58,975,000	—	31 Dec 2015	13F
STATE STREET CORP	13F	Company	16%	3,328,749	$56,093,000	—	31 Dec 2015	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	16%	3,295,092	$55,522,000	—	31 Dec 2015	13F
JANUS HENDERSON INVESTORS US LLC	13F	Company	11%	2,369,215	$39,921,000	—	31 Dec 2015	13F
BLACKROCK ADVISORS LLC	13F	Company	11%	2,342,182	$39,466,000	—	31 Dec 2015	13F
NORGES BANK	13F	Company	10%	2,134,205	$35,961,000	—	31 Dec 2015	13F
Granahan Investment Management, LLC	13F	Company	10%	2,082,155	$35,084,000	—	31 Dec 2015	13F
Bank of New York Mellon Corp	13F	Company	9%	1,869,414	$31,499,000	—	31 Dec 2015	13F
FMR LLC	13F	Company	8.2%	1,709,803	$28,810,000	—	31 Dec 2015	13F
Artal Group S.A.	13F	Company	7.7%	1,600,000	$26,960,000	—	31 Dec 2015	13F
BRIDGER MANAGEMENT, LLC	13F	Company	7.5%	1,563,862	$26,351,000	—	31 Dec 2015	13F
NORTHERN TRUST CORP	13F	Company	7.5%	1,561,947	$26,318,000	—	31 Dec 2015	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	6.5%	1,355,677	$22,843,000	—	31 Dec 2015	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	5.8%	1,208,204	$20,359,000	—	31 Dec 2015	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	5.3%	1,099,867	$18,533,000	—	31 Dec 2015	13F
DEUTSCHE BANK AG\	13F	Company	5.1%	1,051,890	$17,722,000	—	31 Dec 2015	13F
JPMORGAN CHASE & CO	13F	Company	4.9%	1,022,549	$17,230,000	—	31 Dec 2015	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	4.6%	961,613	$16,204,000	—	31 Dec 2015	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	4.4%	907,683	$15,294,000	—	31 Dec 2015	13F
RICE HALL JAMES & ASSOCIATES, LLC	13F	Company	4.3%	899,531	$15,157,000	—	31 Dec 2015	13F
SYSTEMATIC FINANCIAL MANAGEMENT LP	13F	Company	4.3%	885,417	$14,919,000	—	31 Dec 2015	13F
Cormorant Asset Management, LP	13F	Company	3.7%	765,156	$12,893,000	—	31 Dec 2015	13F
Artisan Partners Limited Partnership	13F	Company	3.5%	719,060	$12,116,000	—	31 Dec 2015	13F
GUGGENHEIM CAPITAL LLC	13F	Company	3.4%	702,643	$11,840,000	—	31 Dec 2015	13F
BlackRock Investment Management, LLC	13F	Company	3.1%	636,866	$10,731,000	—	31 Dec 2015	13F
AMERIPRISE FINANCIAL INC	13F	Company	3%	616,119	$10,382,000	—	31 Dec 2015	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	2.9%	600,840	$10,124,000	—	31 Dec 2015	13F
HARVEY CAPITAL MANAGEMENT INC	13F	Company	2.9%	598,400	$10,083,000	—	31 Dec 2015	13F
Rhenman & Partners Asset Management AB	13F	Company	2.8%	581,000	$9,790,000	—	31 Dec 2015	13F
S.c.a. Candriam	13F	Individual	2.4%	500,200	$8,428,000	—	31 Dec 2015	13F
MORGAN STANLEY	13F	Company	2.3%	485,172	$8,175,000	—	31 Dec 2015	13F
GOLDMAN SACHS GROUP INC	13F	Company	2.2%	462,167	$7,788,000	—	31 Dec 2015	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	2.2%	458,288	$7,723,000	—	31 Dec 2015	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	2.1%	427,200	$7,198,000	—	31 Dec 2015	13F
CREDIT SUISSE AG/	13F	Company	2%	408,152	$6,876,000	—	31 Dec 2015	13F
EverPoint Asset Management, LLC	13F	Company	1.9%	400,000	$6,740,000	—	31 Dec 2015	13F
ArrowMark Colorado Holdings LLC	13F	Company	1.9%	397,905	$6,705,000	—	31 Dec 2015	13F
D. E. Shaw & Co., Inc.	13F	Company	1.8%	369,351	$6,223,000	—	31 Dec 2015	13F
Opus Point Partners Management, LLC	13F	Company	1.7%	348,583	$5,874,000	—	31 Dec 2015	13F
Cupps Capital Management, LLC	13F	Company	1.7%	347,015	$5,847,000	—	31 Dec 2015	13F
BLAIR WILLIAM & CO/IL	13F	Company	1.6%	329,545	$5,552,000	—	31 Dec 2015	13F
MARSHALL WACE, LLP	13F	Company	1.6%	324,124	$5,462,000	—	31 Dec 2015	13F
PRUDENTIAL FINANCIAL INC	13F	Company	1.5%	307,873	$5,188,000	—	31 Dec 2015	13F

Institutional Holders of Nektar Therapeutics - Common Stock (NKTR) as of Q1 2016

As of 31 Mar 2016, Nektar Therapeutics - Common Stock (NKTR) was held by 172 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 139,138,306 shares. The largest 10 holders included OppenheimerFunds, Inc., PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, BlackRock Fund Advisors, Camber Capital Management LLC, Invesco Ltd., BRIDGER MANAGEMENT, LLC, STATE STREET CORP, BlackRock Institutional Trust Company, N.A., and RA CAPITAL MANAGEMENT, LLC. This page lists 172 institutional shareholders reporting positions in this security for the Q1 2016 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2016 vs Q4 2015 Across Filers

Q4 2015 holders

177

Q1 2016 holders

172

Holder diff

-5

Investor	Q4 2015 Shares	Q1 2016 Shares	Share Diff	Share Chg %	Q4 2015 Value $	Q1 2016 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.